Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. NULISA
BrandsNULISA

How AI describes NULISA

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

NULISA logoNULISAalamarbio.com

Parse Score

47.3

#101 of 121 in Biopharma Research Platforms and Services

Strength22
Reach42
Authority0
Ownership
Part ofAlamar Biosciences logoAlamar Biosciences
NULISA logoNULISA

Work at NULISA?

Claim this profile for the full report: every prompt where NULISA appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor NULISA

Sources

pmc.ncbi.nlm.nih.gov shapes more of what AI says about NULISA than any other source, at 29% of its citations.

broadclinicallabs.org · precisionformedicine.com · pubmed.ncbi.nlm.nih.gov · quanterix.com

AI questions where NULISA appears

Always know where you stand in AI

Start monitoring NULISA

The market map

Biopharma Research Platforms and Services →
10%20%Category leadersSpecialistsIn the mixLong tailNamed in more AI answers →Appears earlier in the answer →OlinkU.S. Food and Dr…Insilico MedicineRecursionNVIDIAUniversity of Co…Alamar BiosciencesBioptimusIBMPharma.aiAlphabetQuanterixIsomorphic LabsNational Institu…

Where AI ranks NULISA

Biopharma Research Platforms and Services#101
  • Excerpts where NULISA appeared in the AI's answer

    Google AI Mode · excerpt
    NULISA™ (Nucleic Acid Linked Immuno-Sandwich Assay): A newer technology frequently benchmarked against Olink and MSD for low-volume, high-multiplexing capabilities in CNS and inflammatory studies.
    Google AI Mode · excerpt
    NULISA (Alamar Biosciences) and Olink are preferred when dealing with very low sample volumes